Literature DB >> 20377748

Changes in impact of HLA class I allele expression on HIV-1 plasma virus loads at a population level over time.

Michiko Koga1, Ai Kawana-Tachikawa, David Heckerman, Takashi Odawara, Hitomi Nakamura, Tomohiko Koibuchi, Takeshi Fujii, Toshiyuki Miura, Aikichi Iwamoto.   

Abstract

HLA class I allele types have differential impacts on the level of the pVL and outcome of HIV-1 infection. While accumulations of CTL escape mutations at population levels have been reported, their actual impact on the level of the pVL remains unknown. In this study HLA class I types from 141 untreated, chronically HIV-1 infected Japanese patients diagnosed from 1995-2007 were determined, and the associations between expression of individual HLA alleles and level of pVL analyzed. It was found that the Japanese population has an extremely narrow HLA distribution compared to other ethnic groups, which may facilitate accumulation of CTL escape mutations at the population level. Moreover while they uniquely lack the most protective HLA-B27/B57, they commonly express the alleles that are protective in Caucasians (A11:10.4%, A26:11.55%, B51:8.6% and Cw14:12.7%). Cross-sectional analyses revealed no significant associations between expression of individual alleles and the level of the pVL. The patients were then stratified by the date of HIV diagnosis and the analyses repeated. It was found that, before 2001, B51+ individuals displayed significantly lower pVL than the other patients (median: 5150 vs. 18,000 RNA copies/ml, P=0.048); however thereafter this protective effect waned and disappeared, whereas no changes were observed for any other alleles over time. These results indicate that, at a population level, some HLA alleles have been losing their beneficial effects against HIV disease progression over time, thereby possibly posing a significant challenge for HIV vaccine development. However such detrimental effects may be limited to particular HLA class I alleles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20377748     DOI: 10.1111/j.1348-0421.2010.00206.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  13 in total

Review 1.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

2.  Immune-mediated attenuation of HIV-1.

Authors:  Denis R Chopera; Jaclyn K Wright; Mark A Brockman; Zabrina L Brumme
Journal:  Future Virol       Date:  2011-08       Impact factor: 1.831

3.  Significant reductions in Gag-protease-mediated HIV-1 replication capacity during the course of the epidemic in Japan.

Authors:  Shigeru Nomura; Noriaki Hosoya; Zabrina L Brumme; Mark A Brockman; Tadashi Kikuchi; Michiko Koga; Hitomi Nakamura; Tomohiko Koibuchi; Takeshi Fujii; Jonathan M Carlson; David Heckerman; Ai Kawana-Tachikawa; Aikichi Iwamoto; Toshiyuki Miura
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

4.  Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response.

Authors:  Raghavan Sampathkumar; Elnaz Shadabi; Ma Luo
Journal:  Adv Virol       Date:  2012-05-16

5.  Definition of the viral targets of protective HIV-1-specific T cell responses.

Authors:  Beatriz Mothe; Anuska Llano; Javier Ibarrondo; Marcus Daniels; Cristina Miranda; Jennifer Zamarreño; Vanessa Bach; Rosario Zuniga; Susana Pérez-Álvarez; Christoph T Berger; Maria C Puertas; Javier Martinez-Picado; Morgane Rolland; Marilu Farfan; James J Szinger; William H Hildebrand; Otto O Yang; Victor Sanchez-Merino; Chanson J Brumme; Zabrina L Brumme; David Heckerman; Todd M Allen; James I Mullins; Guadalupe Gómez; Philip J Goulder; Bruce D Walker; Jose M Gatell; Bonaventura Clotet; Bette T Korber; Jorge Sanchez; Christian Brander
Journal:  J Transl Med       Date:  2011-12-07       Impact factor: 5.531

Review 6.  HIV-1 dynamics: a reappraisal of host and viral factors, as well as methodological issues.

Authors:  Heather A Prentice; Jianming Tang
Journal:  Viruses       Date:  2012-10-10       Impact factor: 5.048

7.  Switching and emergence of CTL epitopes in HIV-1 infection.

Authors:  Chungyong Han; Ai Kawana-Tachikawa; Akihisa Shimizu; Dayong Zhu; Hitomi Nakamura; Eisuke Adachi; Tadashi Kikuchi; Michiko Koga; Tomohiko Koibuchi; George F Gao; Yusuke Sato; Atsushi Yamagata; Eric Martin; Shuya Fukai; Zabrina L Brumme; Aikichi Iwamoto
Journal:  Retrovirology       Date:  2014-05-21       Impact factor: 4.602

8.  Noncytolytic CD8+ Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques.

Authors:  Aneela Javed; Nicole Leuchte; Berit Neumann; Sieghart Sopper; Ulrike Sauermann
Journal:  PLoS One       Date:  2015-11-09       Impact factor: 3.240

9.  Rapid HIV-1 Disease Progression in Individuals Infected with a Virus Adapted to Its Host Population.

Authors:  Jiro Katoh; Ai Kawana-Tachikawa; Akihisa Shimizu; Dayong Zhu; Chungyong Han; Hitomi Nakamura; Michiko Koga; Tadashi Kikuchi; Eisuke Adachi; Tomohiko Koibuchi; George F Gao; Zabrina L Brumme; Aikichi Iwamoto
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

Review 10.  Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?

Authors:  Nicole B Crux; Shokrollah Elahi
Journal:  Front Immunol       Date:  2017-07-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.